Log in to your Inderes Free account to see all free content on this page.
Oncopeptides
1.46 SEK
+6.33 %
Less than 1K followers
ONCO
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Oncopeptides
EV/S
Median 2021-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 80.43 | 107.56 | 5.32 | 7.70 | 4.86 | 1.38 | 4.53 |
| Shares | 81.5 | 98.4 | 118.8 | 142.6 | 142.7 | 237.5 | 274.0 |
| Market cap | 6,559.3 | 10,583.3 | 632.5 | 1,098.0 | 692.8 | 328.7 | 1,242.4 |
| Enterprise value | 5,633.2 | 9,743.1 | 270.3 | 753.5 | 625.8 | 272.1 | - |
| EV/S | - | - | 2.3 | 90.1 | 17.8 | 8.6 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 8.23 | 18.35 | 3.00 | 3.73 | 12.20 | 6.06 | -21.10 |
| P/S | - | - | 5.3 | 131.3 | 19.7 | 10.4 | 17.5 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 80.2 % | 60.9 % | 48.0 % | 76.4 % | 23.8 % | 22.2 % | -43.7 % |
| Gearing ratio | - | - | - | - | 187.5 % | 224.5 % | -215.1 % |
Login required
This content is only available for logged in users